Compare DNA & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNA | MG |
|---|---|---|
| Founded | 2008 | 1978 |
| Country | United States | United States |
| Employees | 485 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 481.7M |
| IPO Year | N/A | 2008 |
| Metric | DNA | MG |
|---|---|---|
| Price | $10.04 | $18.68 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 142.7K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | N/A | ★ $700,970,000.00 |
| Revenue This Year | N/A | $5.47 |
| Revenue Next Year | N/A | $3.59 |
| P/E Ratio | ★ N/A | $36.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.37 | $7.06 |
| 52 Week High | $17.58 | $19.36 |
| Indicator | DNA | MG |
|---|---|---|
| Relative Strength Index (RSI) | 71.52 | 66.94 |
| Support Level | $9.87 | $13.75 |
| Resistance Level | $10.06 | $19.36 |
| Average True Range (ATR) | 0.65 | 0.63 |
| MACD | 0.22 | 0.01 |
| Stochastic Oscillator | 82.94 | 72.31 |
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.